Inventor · disambiguated record
Elbert Chin
Also filed as: CHIN ELBERT
29 granted patents·13 pending applications·133 citations·filing 2004–2025
95Inventor score
Files withGILEAD SCIENCES INC29HOFFMANN LA ROCHE6CHIN ELBERT3BILOTTA JOSEPH A1BRAMELD KENNETH ALBERT1
Top patents by PatentIndex Score
42 records- 0198US11078208B1HIV inhibitor compoundsGILEAD SCIENCES INC·Filed 2020·Granted Aug 3, 2021·13 cites·23 claims
- 0298US10294234B2HIV inhibitor compoundsGILEAD SCIENCES INC·Filed 2018·Granted May 21, 2019·43 cites·26 claims
- 0396US11702404B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2020·Granted Jul 18, 2023·9 cites·3 claims
- 0495US11858918B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted Jan 2, 2024·7 cites·18 claims
- 0595US10752636B2HIV inhibitor compoundsGILEAD SCIENCES INC·Filed 2019·Granted Aug 25, 2020·7 cites·58 claims
- 0694US12084455B2HIV inhibitor compoundsGILEAD SCIENCES INC·Filed 2021·Granted Sep 10, 2024·2 cites·18 claims
- 0793US10336762B2Pyrrolo[1,2-b]pyridazine derivativesGILEAD SCIENCES INC·Filed 2018·Granted Jul 2, 2019·8 cites·125 claims
- 0892US12121511B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2021·Granted Oct 22, 2024·3 cites·39 claims
- 0992US11702414B2Thiadiazole IRAK4 inhibitorsGILEAD SCIENCES INC·Filed 2021·Granted Jul 18, 2023·2 cites·4 claims
- 1091US11046686B2Thiadiazole IRAK4 compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jun 29, 2021·5 cites·23 claims
- 1190US12479853B2HIV inhibitor compoundsGILEAD SCIENCES INC·Filed 2024·Granted Nov 25, 2025·0 cites·5 claims
- 1290US10875866B2Pyrrolo[1,2-B]pyridazine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Dec 29, 2020·6 cites·6 claims
- 1390US8158631B2Heterocyclic antiviral compoundsCHIN ELBERT·Filed 2010·Granted Apr 17, 2012·14 cites·15 claims
- 1486US11535622B2Pyrrolo[1,2-b] pyridazine derivativesGILEAD SCIENCES INC·Filed 2020·Granted Dec 27, 2022·1 cites·30 claims
- 1582US12415808B2Pyrrolo[1,2-b]pyridazine derivativesGILEAD SCIENCES INC·Filed 2022·Granted Sep 16, 2025·0 cites·4 claims
- 1682US8273773B2Heterocyclic antiviral compoundsBRAMELD KENNETH ALBERT·Filed 2009·Granted Sep 25, 2012·11 cites·33 claims
- 1778US12497382B2GLP-1R modulating compoundsGILEAD SCIENCES INC·Filed 2023·Granted Dec 16, 2025·0 cites·10 claims
- 1876US11052087B2Anti-HIV compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jul 6, 2021·1 cites·86 claims
- 1973US12448388B2PRMT5 inhibitors and uses thereofGILEAD SCIENCES INC·Filed 2024·Granted Oct 21, 2025·0 cites·18 claims
- 2072US2025099431A1Glp-1r modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2167US12497408B2Tetracyclic compounds and methods for the treatment of Zika virus infectionGILEAD SCIENCES INC·Filed 2022·Granted Dec 16, 2025·0 cites·1 claims
- 2267US9693997B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Jul 4, 2017·1 cites·19 claims
- 2366US2023021705A1Glp-1r modulating compoundsGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 2465US12060351B2Thiadiazole IRAK4 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Aug 13, 2024·0 cites·7 claims
- 2563US2025312352A1Glp-1r modulating compoundsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2662US2025388585A1Prmt5 inhibitors and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2761US12037340B2Pentacyclic derivatives as Zika virus inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Jul 16, 2024·0 cites·6 claims
- 2860US2024254118A1Prmt5 inhibitors and uses thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2959US2025154172A1Prmt5 inhibitors and uses thereofGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3058US2014010783A1Antiviral compoundsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3152US2010029689A1Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2009·Application pending·0 cites
- 3250US9540345B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Jan 10, 2017·0 cites·2 claims
- 3349US8067442B2Heterocyclic antiviral compoundsCHIN ELBERT·Filed 2009·Granted Nov 29, 2011·0 cites·12 claims
- 3447US11572362B2Pyrrolo[1,2-b]pyridazine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Feb 7, 2023·0 cites·10 claims
- 3547US11053250B2Pyrrolo[1,2-b]pyridazine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Jul 6, 2021·0 cites·31 claims
- 3647US9617260B2Inhibitors of bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2014·Granted Apr 11, 2017·0 cites·21 claims
- 3745US9896433B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Feb 20, 2018·0 cites·15 claims
- 3845US2005124607A15-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonistsFiled 2004·Application pending·0 cites
- 3942US2017081312A1Antiviral compoundsHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 4041US2015307461A1Antiviral compoundsBILOTTA JOSEPH A·Filed 2015·Application pending·0 cites
- 4139US2017342068A1Compounds for the treatment of hepatitis b virus infectionGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 4235US2010297073A1Heterocyclic antiviral compoundsCHIN ELBERT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elbert Chin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →